VenoStent is a medical device company that develops an absorbable wrap designed to improve the outcomes of blood vessel surgeries, such as dialysis and bypass procedures. VenoStent addresses a critical problem: nearly half of the 10 million annual dialysis and bypass surgeries fail due to complications related to blood vessel healing and patency.
Their core product is a bioabsorbable wrap that surgeons place around blood vessels during vascular procedures. This wrap is engineered to support the vessel as it heals, reducing the risk of failure by promoting proper blood flow and preventing complications such as neointimal hyperplasia—a common cause of graft failure. The device ultimately dissolves over time, eliminating the need for removal and reducing long-term risks for the patient. VenoStent leverages advanced medical device manufacturing and 3D printing within the healthcare sector to deliver this innovative solution.
What technology breakthrough does VenoStent leverage?
VenoStent's breakthrough centers on the use of absorbable biomaterials and precise engineering to create a scaffold that supports blood vessels during the critical healing phase after surgery. By using a material that the body safely absorbs, VenoStent combines the benefits of mechanical support with the advantage of leaving no permanent foreign object in the vessel, addressing both short-term and long-term complications seen in vascular surgeries.
Who uses VenoStent's technology?
The primary users of VenoStent’s technology are vascular surgeons and hospitals performing procedures such as arteriovenous (AV) fistula creation for dialysis access and peripheral bypass surgeries. The technology is aimed at improving surgical outcomes, reducing repeat interventions, and ultimately enhancing patient quality of life. Its potential impact is significant in the United States and globally, especially among healthcare providers treating patients with kidney failure or advanced vascular disease.
Who are VenoStent's competitors?
VenoStent operates in the vascular surgery device market, which includes several companies focused on improving outcomes for dialysis access and bypass surgeries. Notable competitors and alternatives include:
- Gore Medical – Known for its vascular grafts and stent grafts, Gore is a longstanding incumbent with a broad range of solutions for vascular access.
- Getinge (Maquet) – Offers vascular graft products targeting similar surgical indications, with a focus on synthetic, permanent devices.
- Vascudyne – Develops tissue-engineered vascular grafts, offering a regenerative approach to vascular repair.
- Humacyte – Focuses on bioengineered human tissues for vascular and other surgical applications.
VenoStent differentiates itself by offering an absorbable wrap rather than a permanent implant, aiming for a solution that supports natural vessel healing and reduces long-term complications.
Use PromptLoop to Uncover Company Data
Looking for more company insights like this? PromptLoop helps you go deeper, providing unique data points and analysis on companies like VenoStent and many others. Automate your research and find the information that matters most. Discover how PromptLoop can accelerate your market intelligence. Get A Free Demo to learn more.